Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Mean Arterial Pressure (MAP) Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
search
Join
FREE
This site is intended for healthcare professionals
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Mean Arterial Pressure (MAP) Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
Join
FREE
Edition
European
US
Urology
Filter
Journals
About
Congress reviews
Abstracts
Articles
Podcasts
Videos & Webinars
News
Infographics
Submit A Paper
Plasma Proteins Identify Urological Cancer Risk Targets
April 2026
Plasma protein biomarkers identified through Mendelian randomisation reveal causal links to urological cancer risk and highlight targets for future therapies.
Read more
28 Apr 2026
Plasma Proteins Identify Urological Cancer Risk Targets
Plasma protein biomarkers identified through Mendelian randomisation reveal causal links to urological cancer risk and highlight targets for future therapies.
25 Apr 2026
Lifestyle Factors Impact Cognitive Outcomes in Prostate Cancer
Study links physical activity, smoking, and BMI to cognitive and emotional outcomes in prostate cancer, with statistically significant differences across groups.
23 Apr 2026
Liquid Biopsy Shows Promise in High-Risk Localised Prostate Cancer
Liquid biopsy shows high success for genomic profiling in high-risk localised prostate cancer, outperforming tissue samples despite low ctDNA levels.
21 Apr 2026
Robotic Ureteric Reimplantation Demonstrates Safety and Efficacy
Robotic ureteric reimplantation is safe and effective for benign disease, with low complication rates and stable renal function, according to a UK study.
18 Apr 2026
Pelvic Floor Workout Reduces Postpartum Stress Urinary Incontinence
A structured pelvic floor workout during pregnancy significantly reduces postpartum stress urinary incontinence in first-time mothers, a new trial finds.
16 Apr 2026
ADT Intensification May Not Improve Prostate Cancer Survival
ADT intensification did not improve overall survival in prostate cancer, with worse cancer-specific outcomes seen in real-world patients over 25 years.
14 Apr 2026
Catheter Reinsertion Drives CAUTI in Pelvic Fractures
Repeated catheterisation, not duration alone, increases CAUTI risk in pelvic fracture patients, with infection rates rising sharply after multiple replacements.
11 Apr 2026
Pelvic Floor Training in Pregnancy Reduces Severe Birth Trauma
Antenatal pelvic floor training may lower severe perineal trauma and shorten labour in first-time mothers, new clinical trial findings suggest.
Loading posts...
1
2
3
…
49
Next »
We’ve noticed you’re accessing
from
North/South America.
View
View